BioNTech is a biotechnology company based in Germany that is primarily known for its work in developing immunotherapies, particularly for cancer treatment and vaccine development. The company gained significant global recognition for its role in creating one of the first approved mRNA vaccines for COVID-19, in collaboration with Pfizer. BioNTech focuses on personalized medicine and utilizes advanced technology platforms, including messenger RNA (mRNA), to develop therapies that can trigger the body’s immune system to fight diseases more effectively. It is committed to delivering innovative therapies that address unmet medical needs in oncology and infectious diseases.
Uspeh mRNA cepiva podjetja BioNTech prehaja v novo poglavje, osredotočeno na terapije raka. Podjetje je poročalo o upadu dobička na delnico na 1,08 evra, vendar je preseglo tržna pričakovanja. Prihodki…